Lupus anticoagulant is frequent in patients with Covid‐19
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.14867
Abstract: Patients hospitalized for Covid-19 severe infection are more prone to excessive coagulation activation leading to thrombotic events. Tang et al.1 discussed the importance of high D-dimer and Fibrin degradation product level to determine the patient… read more here.
Keywords: patients covid; anticoagulant frequent; lupus anticoagulant; frequent patients ... See more keywords
Response to “Lupus anticoagulant is frequent in patients with Covid‐19”
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.14890
Abstract: Abstract We appreciate the opportunity to respond to the letter from Dr. Inès Harzallah, et al. Antiphospholipid antibody assays including lupus anticoagulant (LAC), anticardiolipin and anti–β2‐glycoprotein I have also been performed in dozens of our… read more here.
Keywords: anticoagulant frequent; frequent patients; response lupus; patients covid ... See more keywords
AB0379 Musculoskeletal involvements in giant cell arteritis
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.3798
Abstract: Background Joint involvement is frequent in Giant cell arteritis (GCA), mostly polymyalgia rheumatica (PMR). The aim of this study was to describe clinical features of joint involvement in GCA. Objectives To compare patients according to… read more here.
Keywords: giant cell; patients gca; cell arteritis; frequent patients ... See more keywords